Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021


HomeEXECUTIVESNew President Named: CIVCO Radiotherapy

New President Named: CIVCO Radiotherapy


Geissel is based in CIVCO’s Coralville, Iowa, location

CIVCO Radiotherapy, the leading provider of high quality, innovative, patient-centric radiotherapy solutions, announced today that Nat Geissel has been named president. Geissel has been with CIVCO since 2012 and has served as vice president of marketing and product line management, senior vice president and general manager, and most recently, executive vice president and general manager.

“I am extremely proud of what CIVCO Radiotherapy and its predecessors have accomplished through the years, particularly the past 2 years as we successfully separated our business from our sister company, CIVCO Medical Solution, Multi-Modality Imaging to refocus our commitment to the global markets we serve.  We will continue to develop high quality, innovative, patient-centric radiotherapy solutions to provide a better way of improving patient outcomes,” Geissel said. “I look forward to continuing our work, with the dedicated employees of CIVCO Radiotherapy, to be the leading innovation partner in radiotherapy solutions worldwide.”

Geissel came to CIVCO after a distinguished career in medical imaging, software and medical device businesses. He was previously senior director, cardiology for Cerner Corporation, a leading EMR provider based in Kansas City, MO.  Prior to that, he held leadership positions with Sirtex Medical Inc., an oncology-based medical device company, and DMS Health Technologies, a worldwide distributor of patient monitoring and medical imaging equipment.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy